Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.
Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PØ, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PØ, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M.
Svendsen A, et al. Among authors: immervoll h.
Acta Neuropathol. 2011 Oct;122(4):495-510. doi: 10.1007/s00401-011-0867-2. Epub 2011 Aug 24.
Acta Neuropathol. 2011.
PMID: 21863242
Free PMC article.